The global orthopedic soft tissue repair market size was exhibited at USD 5.52 billion in 2022 and is projected to hit around USD 10.27 billion by 2032, growing at a CAGR of 6.4% during the forecast period 2023 to 2032.
Key Pointers:
Orthopedic Soft Tissue Repair Market Report Scope
Report Coverage |
Details |
Market Size in 2023 |
USD 5.88 Billion |
Market Size by 2032 |
USD 10.27 Billion |
Growth Rate From 2023 to 2032 |
CAGR of 6.4% |
Base Year |
2022 |
Forecast Period |
2023 to 2032 |
Segments Covered |
Application, injury location |
Market Analysis (Terms Used) |
Value (US$ Million/Billion) or (Volume/Units) |
Regional Scope |
North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
Key Companies Profiled |
Arthrex, Inc.; DePuy Synthes, Inc.; Stryker; Wright Medical Group N.V.; Zimmer Biomet; CONMED Corporation; Integra LifeSciences Holding Corporation; Smith & Nephew |
The growing geriatric population, rising demand for minimally invasive procedures, an increasing number of sports injuries are key factors aiding market growth. Soft tissues commonly injured during sporting events and physical training include tendons, muscles, and ligaments. Strains, sprains, and contusions, along with tendinitis and bursitis, are the frequently occurring soft tissue injuries. Even with proper treatment, these injuries may take a long time to heal. The growing incidence of road accidents is expected to further boost the demand for soft tissue repairs. Rotator cuff tear, one of the most common shoulder injuries, is likely to significantly drive the market over the forecast period.
In addition, the increasing adoption of minimally invasive procedures due to growing concern over surgical scars further drives the demand for orthopedic soft tissue repair products. These procedures result in lesser traumas and quicker recovery than invasive ones. As the recovery time is shorter, it reduces patients’ stay in hospitals, thereby cutting down costs associated with surgery and hospital stay. For instance, in the case of knee replacement surgery, traditional open surgeries involve making a vertical incision of 8 to 10 inches over the front of the knee to expose the joint. During minimally invasive knee replacement surgery, fewer muscles and tendons are affected, producing more natural results. Wound closure is also easier and recovery time is shorter than traditional procedures.
Furthermore, technological advancements and innovations are expected to further boost overall growth. Treatments such as nerve root blocks, epidural steroid injection, sacroiliac joint injections, and platelet-rich plasma can be effective in managing complex musculoskeletal and neuromuscular pain caused due to ligament tear. Anatomic footprint reconstruction allows healthcare professionals to arthroscopically place the ACL graft at the center of a patient’s ACL to provide rotational stability to the knee. Also, various industry players, including Zimmer Biomet and NORAKER, have been developing new bioabsorbable soft tissue screws over the past few years.
Application Insights
In 2022, the cruciate ligaments repair segment dominated the market for orthopedic soft tissue repair and accounted for the largest revenue share of 42.8%. The growth is attributed to the increasing incidence of ACL injuries during sporting activities. Soccer and baseball players commonly suffer such types of injury. According to the American Journal of Sports Medicine, the incidence of ACL injury is 68.6/100,000 individuals per year. The increase in the number of sports activities is leading to a rise in the number of sports injuries among athletes, which is further propelling the demand for improved orthopedic soft tissue repair products. As per our estimates in 2018, nearly 399,431 reconstruction procedures were carried out in the U.S., and the number is expected to reach 787,463 by 2025.
This segment is anticipated to register the fastest growth during the forecast period. Injuries to the ACL account for 40% to 50% of all knee ligament injuries. Increasing incidence of knee injuries and the introduction of innovative and technologically advanced products, which are cost-effective and patient-friendly, are among the major factors likely to drive the adoption of these surgeries. Moreover, an increase in awareness about potential threats of developing arthritis from uncorrected ACL tears and injuries is expected to push patients to opt for either invasive or minimally invasive surgeries.
Injury Location Insights
In 2022, the knee application segment dominated the market for orthopedic soft tissue repair and held the largest revenue share of 42.0%. This growth is owing to the greater applicability and acceptability of orthopedic soft tissue repair surgeries and increasing adoption of treatment options in developed and emerging countries. Soft tissue knee injuries are one of the most common musculoskeletal disorders, with the increasing prevalence of knee tissue tears, wear downs or impairments related to sports injuries, age-related issues, trauma, and accidents. In addition, the acceptance and affordability of available treatment options are expected to further drive market growth. In the Global Burden of Diseases (GBD) study of 2017, the impact of musculoskeletal injuries accounted for 16% of all years lived with disability, making it the highest contributor to the global disability index.
However, the hip segment is anticipated to register the fastest growth in the market for orthopedic soft tissue repair during the forecast period. Its rapid growth can be attributed to the increasing incidence of hip joint dysfunction caused by soft tissue injuries. Soft tissue injuries surrounding the hip joint may result in joint dysfunction. Some of the focus areas for hip pathology over the recent years included impingement in the hip and hip labrum tears. With increasing incidences of labral tears, chondral damage, and ligamentum teres lesions of deep soft tissues in the hips, which cannot be corrected or treated effectively with physiotherapy, this segment is gaining attention and driving market players to innovate devices and therapies to provide adequate treatment.
Regional Insights
North America dominated the orthopedic soft tissue repair market and accounted for the largest revenue share of 47.7% in 2022 due to the growing number of knee arthroscopies performed in the region. For instance, as per an article published by the Osteoarthritis Research Society International, out of 1 million knee arthroscopies performed annually in the U.S., 700,000 of them involved the meniscus. Another key factor driving the regional growth is attributed to rising healthcare expenditure and investments in healthcare infrastructure as an increase in healthcare spending can help make expensive orthopedic soft tissue repair surgeries more affordable. For instance, according to NHE data demonstrated by KFF, the total national health expenditure of the U.S. increased from USD 3,178 billion in 2015 to USD 3,795 billion in 2019.
However, in Asia Pacific, the market for orthopedic soft tissue repair is anticipated to register the fastest growth during the forecast period owing to the increasing prevalence of musculoskeletal disorders and rising disposable income. Higher penetration of local manufacturers of medical devices is providing significant growth opportunities for the market in the region. Furthermore, the other key factors driving the market are ongoing research in this field, particularly in Japan and India, and the large geriatric population at risk of musculoskeletal disorders. For instance, Japan is considered to be the country with the highest geriatric population in the region.
Some of the prominent players in the Orthopedic Soft Tissue Repair Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Orthopedic Soft Tissue Repair market.
By Application
By Injury Location
By Region
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Orthopedic Soft Tissue Repair Market, By Application
7.1. Orthopedic Soft Tissue Repair Market, by Application, 2023-2032
7.1.1. Rotator Cuff Repair
7.1.1.1. Market Revenue and Forecast (2020-2032)
7.1.2. Epicondylitis
7.1.2.1. Market Revenue and Forecast (2020-2032)
7.1.3. Achilles Tendinosis Repair
7.1.3.1. Market Revenue and Forecast (2020-2032)
7.1.4. Pelvic Organ Prolapse
7.1.4.1. Market Revenue and Forecast (2020-2032)
7.1.5. Gluteal Tendon Repair
7.1.5.1. Market Revenue and Forecast (2020-2032)
7.1.6. Cruciate Ligaments Repair
7.1.6.1. Market Revenue and Forecast (2020-2032)
7.1.7. Hip Arthroscopy
7.1.7.1. Market Revenue and Forecast (2020-2032)
7.1.8. Biceps Tenodesis
7.1.8.1. Market Revenue and Forecast (2020-2032)
7.1.9. Others
7.1.9.1. Market Revenue and Forecast (2020-2032)
Chapter 8. Global Orthopedic Soft Tissue Repair Market, By Injury Location
8.1. Orthopedic Soft Tissue Repair Market, By Injury Location, 2023-2032
8.1.1. Knee
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Shoulder
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Hip
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Small Joints
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Orthopedic Soft Tissue Repair Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Application (2020-2032)
9.1.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Application (2020-2032)
9.1.3.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Application (2020-2032)
9.1.4.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Application (2020-2032)
9.2.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Application (2020-2032)
9.2.3.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Application (2020-2032)
9.2.4.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Application (2020-2032)
9.2.5.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Application (2020-2032)
9.2.6.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Application (2020-2032)
9.3.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Application (2020-2032)
9.3.3.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Application (2020-2032)
9.3.4.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Application (2020-2032)
9.3.5.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Application (2020-2032)
9.3.6.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Application (2020-2032)
9.4.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Application (2020-2032)
9.4.3.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Application (2020-2032)
9.4.4.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Application (2020-2032)
9.4.5.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Application (2020-2032)
9.4.6.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Application (2020-2032)
9.5.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Application (2020-2032)
9.5.3.2. Market Revenue and Forecast, By Injury Location (2020-2032)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Application (2020-2032)
9.5.4.2. Market Revenue and Forecast, By Injury Location (2020-2032)
Chapter 10. Company Profiles
10.1. Arthrex, Inc.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. DePuy Synthes, Inc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Stryker
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Wright Medical Group N.V.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Zimmer Biomet
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. CONMED Corporation
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Integra LifeSciences Holding Corporation
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Smith & Nephew.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms